Rare Diseases: Modern Strategies for Enhanced Primary Care

By Thanusha Pillay

July 22, 2024

Introduction: Rare Diseases Are Not as Rare as We Think

Globally, rare diseases affect approximately 300 million people, with estimates of up to 10,000 known rare diseases. Rare diseases are increasingly being recognised as a global health priority, through inclusion in the UN Sustainable Development Goals and the upcoming WHO Resolution on Rare Diseases. People with rare diseases are frequently met with challenges in diagnosis and treatment, and often require specialist, comprehensive healthcare.

The International Rare Diseases Research Consortium (IRDiRC) unites global stakeholders to promote collaboration and advance rare disease research. Covering multiple continents, IRDiRC aims to provide accurate diagnosis and care for all rare disease patients within one year of seeking medical attention. The IRDiRC formed the Primary Care Task Force to identify priority research areas in rare diseases within primary care. This paper in The Lancet Global Health explores they key findings of the task force, with strategies to enhance primary care for rare diseases, focusing on access, early diagnosis, training, and digital initiatives.

Enhancing Primary Care

The WHO defines primary health care as a comprehensive approach that addresses broader health determinants, empowers individuals and communities, and meets essential lifelong health needs.  Primary care providers, including family physicians, general practitioners, pharmacists, and nurses, serve as the initial point of contact for many patients. Primary care is essential to health systems and often the only accessible care in some areas.

Access and Awareness of Rare Diseases

Many individuals with rare diseases remain undiagnosed, presenting complex symptoms that resemble common ailments, leading to misdiagnosis and prolonged diagnostic journeys. With over 72% of rare diseases having a genetic basis, genetic testing is critical in diagnosis. However, insufficient workforce capacity and low reimbursement rates continue to be barriers to accessing genetic services. Moreover, primary care providers face ethical and psychosocial challenges with genetic testing. Expanding genetic services and educating primary care providers on genetic testing and referrals are essential to avoid misdiagnosis and treatment delays.

Improved access to rare disease case-finding resources, can improve referrals to specialist services. Clear guidelines from specialists are essential, but equitable access remains a challenge when genetic services are confined to tertiary centres. To enhance primary care providers’ knowledge and access to genetic services for rare diseases, three strategies were proposed: telegenetics, learning communities, and a collaborative partnership between primary care providers, patients and their families, and clinical genetics providers. These strategies aim to create a patient-centred medical home model for better diagnosis and care.

Early Diagnosis and AI Integration

AI and machine learning can expedite diagnosis and improve care by analysing health records to identify suspected genetic diseases. However, increased access to genetic testing does not ensure treatment. Health technology assessment bodies need flexible processes and early collaboration to improve evidence-based decisions in rare disease care.

Training and Education in Rare Diseases

Training and education in rare diseases are crucial when primary care serves as the initial contact for patients. Providers should understand and be able to address the physical, mental, and social needs of rare disease patients. Effective communication between geneticists, specialists, and primary care providers is vital for optimising patient care. Multidisciplinary care clinics can streamline care and reduce the burden on patients and families.

Data Sharing and Digital Health

Data sharing and digital health are key to understanding rare diseases across the lifespan. Effective data capture, coding, and sharing are crucial for expediting diagnosis. Telehealth and digital technologies can manage long-term conditions, improve outcomes, and reduce hospitalisations. However, trust, governance, and secondary use of data hinder data sharing. Primary care providers need to develop data-sharing policies and raise patient awareness about their records.

Summary and Future Directions

Unlocking primary healthcare’s potential to address rare diseases requires a systemic and systematic approach. Key areas include increasing awareness and diagnostic access, targeted training, effective referral pathways, and improved digital strategies. Implementing these recommendations will ultimately improve the quality of life for these patients and reduce the burden on the healthcare system. Future directions should support policy implementation, advocate for equitable funding, address mental health needs, develop better care models, and increase funding for rare diseases.

Reference url

Recent Posts

Egypt Hepatitis C Program
     

Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives

🌍 How can Egypt’s hepatitis C elimination program inspire other African nations?

Discover how Egypt has set a powerful benchmark for public health excellence through its “100 million Healthier Lives” campaign, achieving Gold-tier certification from the WHO. This article looks into the training initiatives and regional collaboration that are paving the way for health improvements across the continent.

#SyenzaNews #GlobalHealth #HealthcareInnovation #Innovation #HealthForAll

Maturity Level 3 regulation
      

Maturity Level 3 in Medicines Regulation in Senegal and Rwanda

🌍 How do robust regulatory systems impact public health globally?

Senegal and Rwanda have made significant strides by achieving WHO Maturity Level 3 in medicines regulation, enhancing their capability to ensure safe and effective medical products. This accomplishment not only fortifies local health standards but also sets a benchmark for other nations to follow, promoting regional collaboration and economic benefits. Discover how this achievement will impact global health outcomes!

#SyenzaNews #globalhealth #regulatoryaffairs #MarketAccess #innovation

95-95-95 HIV targets
     

Advancing the 95-95-95 Targets: A Roadmap to End AIDS by 2030

🌍 How close are we to achieving the **95-95-95 HIV targets**?

Explore the latest insights from UNAIDS on the progress and strategic importance of these targets in ending the HIV/AIDS pandemic by 2030. The framework not only focuses on comprehensive testing and treatment but also emphasizes equity in healthcare access across all demographics.

Read more about how we can collectively strive for a future free from HIV/AIDS-related stigma and health inequities.

#SyenzaNews #GlobalHealth #HealthcareInnovation #Healthforall #FutureofHealthcare

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.